Evidence map›Paper›PMID 37181098›Full record

ArticleFrontiers in medical technology2023

Experiences of medical device innovators as they navigate the regulatory system in Uganda.

Brenda T Nakandi, Owen Muhimbise, Ashley Djuhadi, Martha Mulerwa, Janet McGrath, Philippa Ngaju Makobore, Andrew M Rollins, Robert T Ssekitoleko

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medical technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Brenda T Nakandi *Biomedical Engineering Unit, Department of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Owen Muhimbise *Biomedical Engineering Unit, Department of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Ashley Djuhadi *Department of Macromolecular Science and Engineering, Case Western Reserve University, Cleveland, OH, United States.
Martha MulerwaInstrumentation Division, Uganda Industrial Research Institute, Kampala, Uganda.
Janet McGrathDepartment of Anthropology, Case Western Reserve University, Cleveland, OH, United States.
Philippa Ngaju MakoboreInstrumentation Division, Uganda Industrial Research Institute, Kampala, Uganda.
Andrew M RollinsDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Robert T SsekitolekoBiomedical Engineering Unit, Department of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Case Western Reserve University · USMakerere University · UGUganda Industrial Research Institute · UG

Funding

Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and SurgeryR01EY032633 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI DUPPS, WILLIAM JOSEPH, GRYTZ, RAFAEL · 2022 to 2025
$2.5M
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in UgandaD43TW012260 · FIC · CASE WESTERN RESERVE UNIVERSITY · PI ANDREW Martin ROLLINS, Robert Ssekitoleko · 2022 to 2026
$1.2M
FIC NIH HHS D43 TW012260NEI NIH HHS R01 EY032633
6 · The paper itself

Abstract

Objective: A medical device must undergo rigorous regulatory processes to verify its safety and effectiveness while in use. In low-and middle-income countries like Uganda however, medical device innovators and designers face challenges around bringing a device from ideation to being market-ready. This is mainly attributed to a lack of clear regulatory procedures among other factors. In this paper, we illustrate the current landscape of investigational medical devices regulation in Uganda. Methods: Information about the different bodies involved in regulation of medical devices in Uganda was obtained online. Nine medical device teams whose devices have gone through the Ugandan regulatory system were interviewed to gain insights into their experiences with the regulatory system. Interviews focused on the challenges they faced, how they navigated them, and factors that supported their progress towards putting their devices on the market. Results: We identified different bodies that are part of the stepwise regulatory pathway of investigational medical devices in Uganda and roles played by each in the regulatory process. Experiences of the medical device teams collected showed that navigation through the regulatory system was different for each team and progress towards market readiness was fuelled by funding, simplicity of device, and mentorship. Conclusion: Medical devices regulation exists in Uganda but is characterised by a landscape that is still in development which thereby affects the progress of investigational medical devices.

Indexed as

ideation through market readinessinvestigational medical devicesmedical device clinical trialsmedical devices regulationregulations landscape in Uganda

Identifiers

PMID37181098
PMCPMC10172494
OpenAlexW4367183937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.